Indian Journal of Medical Research

ORIGINAL ARTICLE
Year
: 2019  |  Volume : 149  |  Issue : 2  |  Page : 199--207

Molecular characterization of colistin-resistant Klebsiella pneumoniae & its clonal relationship among Indian isolates


Chaitra Shankar1, Manigandan Venkatesan1, Ranjani Rajan1, Deepa Mani1, Binesh Lal1, John Antony Jude Prakash1, Shalini Anandan1, Agila Kumari Pragasam1, Kamini Walia2, VC Ohri2, Balaji Veeraraghavan1,  
1 Department of Clinical Microbiology, Christian Medical College, Vellore, India
2 Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India

Correspondence Address:
Dr Balaji Veeraraghavan
Department of Clinical Microbiology, Christian Medical College, Vellore 632 004, Tamil Nadu
India

Abstract

Background & objectives: Klebsiella pneumoniae (KP), a common cause of invasive infections, is often extensively drug resistant in India. At present, studies on resistance mechanism and clonal relationship of KP from India are limited. The present study was undertaken to determine the resistance mechanism and clonal relationship of colistin-resistant isolates obtained from various specimens. Carbapenemases were also determined since the isolates were carbapenem resistant. Methods: Sixty five isolates from blood, exudates and respiratory specimens collected between 2016 and 2017 were studied. Colistin minimum inhibitory concentration (MIC) was performed by broth-micro dilution method. Multiplex PCR was carried out to determine carbapenemases. Targeted sequencing was performed to determine mutations in mgrB, phoP, phoQ and multilocus sequence typing was performed to determine the prevalent clones. Results: Colistin MIC ranged from 4 to 256 μg/ml. SHV, TEM and CTX-M were co-produced in 60 per cent and OXA48-like in 71 per cent. Thirteen isolates had mutations in mgrB. Mutations included a premature stop codon at 21st amino acid, the presence of insertion sequences such as IS903, IS Kpn 14 and ISK pn 26; and elongation of mgrB. Novel mutations were also observed among phoP and phoQ genes. Colistin resistance due to mcr genes was absent. Fifteen clonal types were seen with ST231, ST14 and ST2096 being predominant. Interpretation & conclusions: This study revealed the changing trend of carbapenem resistance mechanism predominantly to OXA48-like from NDM. Known mgrB mutations and novel mutations in phoP and phoQ were detected. There was no plasmid-mediated colistin resistance. ST14 and ST231 were international clones associated with carbapenem resistance. Colistin-resistant KP was of diverse clones with predominantly ST231, ST14 and ST2096.



How to cite this article:
Shankar C, Venkatesan M, Rajan R, Mani D, Lal B, Prakash JA, Anandan S, Pragasam AK, Walia K, Ohri V C, Veeraraghavan B. Molecular characterization of colistin-resistant Klebsiella pneumoniae & its clonal relationship among Indian isolates.Indian J Med Res 2019;149:199-207


How to cite this URL:
Shankar C, Venkatesan M, Rajan R, Mani D, Lal B, Prakash JA, Anandan S, Pragasam AK, Walia K, Ohri V C, Veeraraghavan B. Molecular characterization of colistin-resistant Klebsiella pneumoniae & its clonal relationship among Indian isolates. Indian J Med Res [serial online] 2019 [cited 2021 Jan 25 ];149:199-207
Available from: https://www.ijmr.org.in/text.asp?2019/149/2/199/259586


Full Text

Klebsiella pneumoniae (KP) causes a wide spectrum of infections including pneumonia, bacteraemia and skin and soft-tissue infections. The incidence of extensively drug-resistant (XDR, non-susceptible to at least one agent in all classes, but susceptible to ≤2 classes of antimicrobials) isolates have been on the rise [1]. Colistin resistance is mediated by chromosomal mutations and plasmid-borne genes [2]. Chromosomal mutations are predominantly reported in the genes encoding two-component systems (mgrB, phoP, phoQ, pmrA, pmrB) involved in lipopolysaccharide modification [2]. Plasmid-mediated mcr1-5 and its variants encoding phosphoethanolamine transferase contribute to colistin resistance.

At present, studies on molecular characterization of XDR KP (carbapenem and colistin resistant) and clonal relatedness are limited in India. This study was performed to determine the molecular resistance mechanisms and its association with clonal relationship among colistin-resistant KP. Chromosomal colistin resistance contributed by mutations in mgrB, phoP and phoQ and plasmid-mediated mcr-1 and mcr-3 were investigated. Multilocus sequence typing (MLST) to look for clonal types and its relationship with colistin-resistant mechanism were determined in isolates collected from various clinical specimens. Since the study isolates were carbapenem-resistant, carbapenemases were also characterized.

 Material & Methods



Totally 65 colistin-resistant KP isolated from clinical specimens including blood and body fluids (n=43), exudates (n=11) and respiratory specimens (n=11) collected between 2016 and 2017 at the department of Clinical Microbiology, Christian Medical College, Vellore, India, were selected retrospectively. The study protocol was approved by the Institutional Review Board. The isolates were identified up to species level as per standard procedures [3]. First colistin-resistant KP isolate from a patient was included in the study.

Phenotypic characterization: Antimicrobial susceptibility testing was performed as per Clinical and Laboratory Standards Institute (CLSI) guidelines and interpreted based on CLSI 2016 and 2017 breakpoints [4],[5]. The panel of antimicrobials tested included ceftazidime (30 μg), cefotaxime (30 μg), cefepime (30 μg), piperacillin/tazobactam (100/10 μg), imipenem (10 μg), meropenem (10 μg), ciprofloxacin (5 μg), gentamicin (10 μg), netilmicin (30 μg), amikacin (30 μg), minocycline (30 μg) and tigecycline (15 μg). All the isolates were carbapenem resistant which was defined as resistant to meropenem with zone diameter of ≤19 mm [4],[5]. Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923 and Pseudomonas aeruginosa ATCC 27853 were used as control strains for susceptibility testing as recommended by CLSI [4],[5]. Susceptibility to tigecycline was interpreted with FDA breakpoints (http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021821s016lbl.pdf). Colistin minimum inhibitory concentration (MIC) was determined by reference broth-micro dilution method [6],[7]. mcr-1 positive E. coli (Courtesy: Dr Olga Perovic, National Institute for Communicable Diseases, Johannesburg, South Africa) was used as positive control and E. coli ATCC 25922 and P. aeruginosa ATCC 27853 were used as negative controls. MIC results were interpreted as per European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines 2016 and 2017, respectively [6],[7].

Molecular characterization

Characterization of β-lactamases: Bacterial DNA was extracted from 18 h cultures by Qiasymphony (Qiagen, Hilden, Germany) as per manufacturer's instructions. Multiplex PCR was performed for the detection of genes encoding β-lactam resistance which included EBSL (blaSHV, blaTEM, blaPER, blaVEB, blaCTX-M-1, blaCTX-M-2, blaCTX-M-8, blaCTX-M-9 and blaCTX-M-25)[8],[9], AmpC (blaACT, blaACC, blaCIT, blaDHA and blaFOX)[10] and carbapenemases (blaNDM, blaVIM, blaIMP, blaOXA48-like, blaKPC, blaGESand blaSPM)[11],[12],[13]. Known positive controls (Courtesy: International Health Management Association Inc., USA) were used.

Characterization of colistin resistance: Chromosomal mutations: PCR for amplification of mgrB, phoP and phoQ genes was performed as described by Jayol et al[14]. From the amplified product, mutations were determined by targeted sequencing. For analysis of mutations, KP ATCC 35657 was used as reference. To determine insertion sequences present in mgrB, the sequences were run through ISfinder (https://www-is.biotoul.fr/) and the position of insertion was assigned by aligning with reference mgrB. Sequencing was performed using 3500 Genetic Analyzer (Applied Biosystems, USA) as per manufacturer's instructions.

Sorting Intolerant From Tolerant (SIFT) scores for the non-synonymous mutations implicating in the amino acid substitutions were predicted for mgrB, phoP and phoQ genes. A value of <0.05 for a substitution is predicted to be deleterious and affects the function of the protein (https://ionreporter.thermofisher.com/ionreporter/help/GUID-2097F236-C8A2-4E67-862D-0FB5875979AC.html). SIFT score calculates the deleterious effect based on the probability of the substituted amino acid being tolerated at a position.

Plasmid-mediated colistin resistance: To determine plasmid-borne colistin resistance, PCR was performed for mcr-1 and mcr-3 genes, as controls were available for these two mcr variants [15],[16].

Multilocus sequence typing (MLST): MLST was performed as described by Diancourt et al[17]. Seven housekeeping genes used to determine clonal type among KP included gapA (coding for glyceraldehyde-3-phosphate), infB (coding for translation initiation factor-2), mdh (coding for malate dehydrogenase), pgi (coding for phosphoglucose isomerase), phoE (coding for phosphorine E), rpoB (coding for β-subunit of RNA polymerase B) and tonB (coding for periplasmic energy transducer). The sequence type was assigned by determining the allele number for each of the housekeeping genes using the database maintained by Pasteur Institute, Paris, France (http://bigsdb.pasteur.fr/klebsiella/).

Genetic analysis: The relatedness of the predicted sequence types was investigated by eBURST V3 software employing the BURST algorithm [18]. Splits Tree4 programme version 4.14.6 was used to determine the phylogenetic relatedness among the various clonal types based on the seven house-keeping genes that define the MLST [19]. Using the concatenated sequences of seven housekeeping genes of MLST, phylogenetic tree was constructed using MEGA v.7 (https://www.megasoftware.net/) and meta-data were added using iTOL (https://itol.embl.de/login.cgi).

 Results



All the 65 isolates were XDR being resistant to aminoglycosides, cephalosporins and fluoroquinolones and susceptible only to tigecycline; 10 blood isolates were susceptible to minocycline and two isolates each from exudates were susceptible to chloramphenicol and trimethoprim-sulphamethoxazole, respectively. The colistin MIC for the isolates ranged from 4 to 256 μg/ml. The mean colistin MIC value was found to be 19±31.9 μg/ml.

Among the ESBL genes, 60 per cent (n=40) of the isolates co-produced blaSHV, blaTEM and blaCTX-M-15. blaOXA48-like was the predominant carbapenemase gene produced in 71 per cent (n=47) followed by co-production of blaNDM and blaOXA48-like in 11 per cent (n=7), blaNDM in seven per cent (n=5) and blaKPC three per cent (n=2) and four isolates did not produce any of the carbapenemases genes tested. [Figure 1] shows the distribution of β-lactamases among the various clinical specimens.{Figure 1}

Colistin MIC, mutations in mgrB, phoP and phoQ and associated clonal types among the study isolates are shown in the [Table 1]. The mutations in mgrB observed among clinical specimens were among diverse clonal types. [Figure 2]A, [Figure 2]B, [Figure 2]C, [Figure 2]D, [Figure 2]E shows the association of mgrB with insertion sequences. A total of 41 isolates did not have mutations in mgrB and in 11 isolates mgrB gene was absent. Mutations in phoP and phoQ were present among six and nine isolates, respectively. Screening for mcr-1 and mcr-3 genes by PCR was negative for all the isolates.{Table 1}{Figure 2}

SIFT score was calculated to predict the effect of amino acid substitutions identified in this study isolates. In mgrB, both the substitutions Met1Ala and Cys28Gly were found deleterious. In phoP, among the three substitutions observed, Ala114Arg, Glu22Lys showed a score of 0.22 and 0.49, while Thr151Ala scored zero and found significant and deleterious. Similarly, in phoQ, mutations such as Leu205Gln, Leu209Cys, Trp215Ser, Val403Glu, Val446Trp and Phe478Gly were predicted to affect the function of the protein. Non-significant mutations of Trp194Leu (phoQ) in Kp7, Kp8 and Glu22Lys (phoP) in Kp13 were also noted.

Totally, 15 different sequence types were obtained among the 65 isolates and these included ST231 (n=23), ST14 (n=13), ST2096 (n=9), ST 147 (n=5), ST78 (n=3), ST15 (n=2), ST16 (n=2) and one isolate each of ST11, ST17, ST23, ST38, ST43, ST86, ST395 and ST2957. [Figure 3] shows the eBURST analysis for the clonal types among the study isolates. ST17 and ST16 belonged to the same clonal complex; while ST14, ST15, ST78 and ST2096 form another clonal complex, CC14. Other sequence types such as ST11, ST23, ST43, ST147 and ST231 were found as singletons.{Figure 3}

Among the study isolates, KP harbouring carbapenemases were of diverse sequence types. Overall, ST14 was the most predominant. Among the STs, OXA48-like producers were distributed among diverse clonal types such as ST14, ST16, ST17, ST38, ST43, ST231, ST395 and ST2096. Co-producers of blaNDM with blaOXA48(n=6) belonged to ST14, ST78 and ST147. Isolates producing blaNDM(n=6) alone belonged to ST14, ST15, ST23 and ST78. Two of the study isolates were blaKPC producers, each belonging to ST15 and ST2957.

[Figure 4] shows the Splits Tree diagram for the sequence types. All the clonal types were closely related except ST2957 which was an outlier. The outlier was identified as K. quasipneumoniae belonging to phylogenetic group II of KP. [Figure 5] shows the maximum likelihood tree constructed based on the concatenated sequences of seven housekeeping genes used for MLST. As shown, isolates of ST231 were OXA48-like carbapenemase producers and was the predominant clone. The isolates of CC14 were more diverse in carbapenemases producing New Delhi metallo-β-lactamase (NDM) and/ or OXA48-like and one isolate with KPC. [Figure 5] also shows the clones present among different specimen sources. The isolates with chromosomal mutations contributing to colistin resistance [Table 1] are also indicated and the distribution of carbapenemases among these isolates is evident from [Figure 5].{Figure 4}{Figure 5}

 Discussion



In this study molecular resistance mechanisms were assessed and clonal relatedness of colistin-resistant KP was investigated. SHV, TEM and CTX-M-15 were the prevalent β-lactamases similar to earlier study [20]. Among the study isolates, OXA48-like was the commonest carbapenemase produced. In this study, colistin resistance was contributed by mutations in mgrB, phoP and phoQ genes in the isolates. Our earlier study identified truncated mgrB of 27 amino acids due to a premature stop codon and also deletion of A at 10th nucleotide [2]. However, in the present study, these two mutations were absent, but various other mutations were seen. All the mgrB negatives could be due to partial or complete deletion of mgrB as reported previously [21]. The disruption of mgrB due to insertion elements such as IS1R, IS903, ISKpn14 and ISKpn26 similar to the present study have been reported earlier [21],[22],[23]. The mgrB mutations were not associated with specific carbapenemases or specific clones. There was no association between colistin MIC, mgrB mutations and specific clones. Substitutions in the phoP and phoQ genes implicated in colistin resistance have been reported [23]. However, certain mutations observed in the present study were novel. The significance of these novel mutations were predicted using SIFT scores. These scores revealed that the novel mutations were likely to affect protein function. However, detailed functional properties of mutations need to be determined by cloning studies to substantiate its significance.

Clonal relatedness with antimicrobial resistance profile in colistin-resistant KP was determined. New Delhi metallo-β-lactamase (NDM) producing KP are known to be associated with ST11, ST14, ST147 and ST231 in India and globally [2],[24],[25] while the two KPC KP belong to ST15 and ST2957. International KPC clones such as ST258 and ST512 were absent among the study collection.

The colistin-resistant isolates in the present study were diverse and 15 clones were observed among the isolates. ST14, ST231 and ST2096 were predominant. The truncation of mgrB due to IS5-like elements [21],[22] and ISKpn 14[23],[26] has been reported among ST258, ST512 and ST101. ISKpn 26 has been reported among OXA48-like producer belonging to ST307[26]. In the present study, these were seen among isolates belonging to ST14, ST15 and ST231. Substitutions previously reported in phoP[23],[27] and phoQ[23],[27] were among isolates of ST147 and ST258.

Isolate belonging to ST23 produced NDM; also carried rmpA and rmpA2 genes indicating hypervirulent KP. Earlier, carbapenem-resistant hypervirulent KP belonging to ST14 and ST231[28] has been reported. These two clones are classically associated with carbapenem-resistant isolates in India and other countries [2],[20]. A novel ST2957 was observed in the present study. Earlier in India, Shankar et al[29] have reported pan-susceptible hypervirulent K. quasipneumoniae of novel clone ST2320.

The association between the MLST sequence types and the molecular resistance mechanisms was not observed. This could be due to the limited relatedness information provided by MLST. Whole genome SNP-based phylogeny may provide further insights into the strain-specific lineage within a particular sequence type/clonal complex [30]. A previous study revealed that 97 per cent of KPC KP isolates sequenced, regardless of country of isolation, belong to a well-supported clade, corresponding to the complex CC258 based on the whole genome phylogeny [30]. MLST can be used to understand the epidemiology at a large scale while whole genome SNP phylogeny would be discriminatory in local outbreak situations.

The mechanism of colistin resistance in isolates which lacked mutations in mgrB, phoP and phoQ were not determined. This was a limitation of the study since in 70 per cent of study isolates the mechanism of colistin resistance was unidentified.

In conclusion, this study revealed the changing trend of carbapenem resistance mechanism predominantly to OXA48-like from NDM. There is alarming increase in colistin resistance with novel mutations in chromosomal genes such as mgrB, phoP and phoQ. There was no plasmid-mediated colistin resistance. Diverse clones of colistin-resistant isolates were observed with CG14 being predominant. No known international clones such as ST258 and ST512 were observed. It is important to monitor colistin resistance by using appropriate testing method and also limit colistin usage.

Financial support & sponsorship: Fluid Research Grant of the Christian Medical College, Vellore (IRB min. no. 9616 dated 01.09.2015) and the Indian Council of Medical Research, New Delhi (Ref. No: AMR/TF/55/13ECDII dated 23/10/2013) are acknowledged for financial support.

Conflicts of Interest: None.

References

1Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18 : 268-81.
2Pragasam AK, Shankar C, Veeraraghavan B, Biswas I, Nabarro LE, Inbanathan FY, et al. Molecular mechanisms of colistin resistance in Klebsiella pneumoniae causing bacteremia from India - a first report. Front Microbiol 2016; 7 : 2135.
3Koshi M. Myer's and Koshi's manual of diagnostic procedures in medical microbiology and immunology/serology. Vellore, India: Christian Medical College and Hospital; 2001.
4Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 26th ed. CLSI Document M100S. Wayne, PA: CLSI; 2016.
5Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 27th ed. CLSI Document M100. Wayne, PA: CLSI; 2017.
6The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0; 2016. Available from: http://www.eucast.org, accessed on October 15, 2017.
7The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 7.0; 2017. Available from: http://www.eucast.org, accessed on October 15, 2017.
8Dallenne C, Da Costa A, Decré D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in enterobacteriaceae. J Antimicrob Chemother 2010; 65 : 490-5.
9Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 2004; 54 : 735-43.
10Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40 : 2153-62.
11Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 2011; 70 : 119-23.
12Ellington MJ, Kistler J, Livermore DM, Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J Antimicrob Chemother 2007; 59 : 321-2.
13Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45 : 1151-61.
14Jayol A, Nordmann P, Brink A, Poirel L. Heteroresistance to colistin in Klebsiella pneumoniae associated with alterations in the PhoPQ regulatory system. Antimicrob Agents Chemother 2015; 59 : 2780-4.
15Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study. Lancet Infect Dis 2016; 16 : 161-8.
16Yin W, Li H, Shen Y, Liu Z, Wang S, Shen Z, et al. Novel plasmid-mediated colistin resistance gene mcr-3 in Escherichia coli. MBio 2017; 8 : e00543-17.
17Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005; 43 : 4178-82.
18Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. EBURST: Inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 2004; 186 : 1518-30.
19Huson DH, Bryant D. Application of phylogenetic networks in evolutionary studies. Mol Biol Evol 2006; 23 : 254-67.
20Veeraraghavan B, Shankar C, Karunasree S, Kumari S, Ravi R, Ralph R. Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience. Pathog Glob Health 2017; 111 : 240-6.
21Cannatelli A, Giani T, D'Andrea MM, Di Pilato V, Arena F, Conte V, et al. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother 2014; 58 : 5696-703.
22Poirel L, Jayol A, Bontron S, Villegas MV, Ozdamar M, Türkoglu S, et al. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother 2015; 70 : 75-80.
23Pitt ME, Elliott AG, Cao MD, Ganesamoorthy D, Karaiskos I, Giamarellou H, et al. Multifactorial chromosomal variants regulate polymyxin resistance in extensively drug-resistant Klebsiella pneumoniae. Microb Genom 2018; 4 : 1-35.
24Subramanian GK, Soundari PG, Ramanathan V, Krishnan P. Endemic Indian clones of Klebsiella pneumoniae-harbouring New Delhi metallo-beta-lactamase-1 on a hybrid plasmid replicon type: A case of changing New Delhi metallo-beta-lactamase plasmid landscapes in India? Indian J Med Microbiol 2016; 34 : 286-92.
25Giske CG, Fröding I, Hasan CM, Turlej-Rogacka A, Toleman M, Livermore D, et al. Diverse sequence types of Klebsiella pneumoniae contribute to the dissemination of blaNDM-1 in India, Sweden, and the United Kingdom. Antimicrob Agents Chemother 2012; 56 : 2735-8.
26Novović K, Trudić A, Brkić S, Vasiljević Z, Kojić M, Medić D, et al. Molecular epidemiology of colistin-resistant, carbapenemase-producing Klebsiella pneumoniae in Serbia from 2013 to 2016. Antimicrob Agents Chemother 2017; 61. pii: e02550-16.
27Jaidane N, Bonnin RA, Mansour W, Girlich D, Creton E, Cotellon G, et al. Genomic insights into colistin-resistant Klebsiella pneumoniae from a Tunisian teaching hospital. Antimicrob Agents Chemother 2018; 62. pii: e01601-17.
28Shankar C, Nabarro LE, Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Daniel JL, Doss CGP, et al. Draft genome sequences of three hypervirulent carbapenem-resistant Klebsiella pneumoniae isolates from bacteremia. Genome Announc 2016; 4. pii: e01081-16.
29Shankar C, Nabarro LEB, Muthuirulandi Sethuvel DP, Raj A, Devanga Ragupathi NK, Doss GP, et al. Draft genome of a hypervirulent Klebsiella quasipneumoniae subsp. similipneumoniae with novel sequence type ST2320 isolated from a chronic liver disease patient. J Glob Antimicrob Resist 2017; 9 : 30-1.
30Gaiarsa S, Comandatore F, Gaibani P, Corbella M, Dalla Valle C, Epis S, et al. Genomic epidemiology of Klebsiella pneumoniae in Italy and novel insights into the origin and global evolution of its resistance to carbapenem antibiotics. Antimicrob Agents Chemother 2015; 59 : 389-96.